无锡阿科力科技股份有限公司2025 年第一季度报告 证券代码：603722 证券简称：阿科力 无锡阿科力科技股份有限公司 2025 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比上年同 | | | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期 期增减变动幅度 | | | | | (%) | | | 营业收入 | 105,906,386.03 | 103,123,475.90 | 2.70 | | 归属于上市公司股东的净利 润 | -4,825,999.14 | 1,191 ...

无锡阿科力科技股份有限公司2024 年年度报告 公司代码：603722 公司简称：阿科力 无锡阿科力科技股份有限公司 2024 年年度报告 2025 年 4 月 30 日 1 / 219 √适用 □不适用 无锡阿科力科技股份有限公司2024 年年度报告 重要提示 一、本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实性、准确性、 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、 致同会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、公司负责人朱学军、主管会计工作负责人冯莉及会计机构负责人（会计主管人员）冯莉声明： 保证年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 2025年4月28日，公司第四届董事会第十八次会议审议通过了《关于2024年度利润分配预案的 议案》，拟以实施权益分派股权登记日登记的总股本95,700,121股为基数，向全体股东每10股派发 现金红利1元（含税），共计派发现金9,570,012.10元（含税），公司本次利润分配不送红股 ...

宁波美诺华药业股份有限公司2025 年第一季度报告 证券代码：603538 证券简称：美诺华 转债代码：113618 转债简称：美诺转债 宁波美诺华药业股份有限公司 2025 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 (一)主要会计数据和财务指标 | | | 单位：元 | 币种：人民币 | | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期 | 本报告期比上年同期 增减变动幅度(%) | | 营业收入 | 276,483,125.97 | 262,766,361.43 | 5.22 | | 归属于上市公司股东的净利润 | 21,221,727.07 | 14,043,259.71 | 51.12 | | 归属于上市公司股东的扣除非 经常性损益的净利润 | 16,622,403.34 | 20,527,312 ...

辽宁福鞍重工股份有限公司2025 年第一季度报告 证券代码：603315 证券简称：福鞍股份 辽宁福鞍重工股份有限公司 2025 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 信息的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比上年同 | | | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期 期增减变动幅度 | | | | | (%) | | | 营业收入 | 234,502,220.66 | 232,546,245.74 | 0.84 | | 归属于上市公司股东的净利 | 26,431,199.02 | 13,938,2 ...

Financial Performance - The company's revenue for Q1 2025 was CNY 441,541,400.52, representing a year-on-year increase of 19.98% compared to CNY 368,013,778.18 in the same period last year[4] - Net profit attributable to shareholders was CNY 44,118,698.94, up 16.99% from CNY 37,711,414.35 in the previous year[4] - The basic earnings per share increased to CNY 0.1728, reflecting a growth of 16.99% compared to CNY 0.1477 in the same period last year[4] - Total operating revenue for Q1 2025 reached ¥441.54 million, a 20% increase from ¥368.01 million in Q1 2024[16] - Net profit for Q1 2025 was ¥44.33 million, representing a 19% increase compared to ¥37.35 million in Q1 2024[17] - Operating profit for Q1 2025 was ¥50.91 million, an increase of 19% from ¥42.80 million in Q1 2024[17] Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,175,938,308.00, an increase of 2.70% from CNY 2,118,773,194.72 at the end of the previous year[5] - Total assets as of March 31, 2025, amounted to CNY 2,175,938,308, an increase from CNY 2,118,773,194.72 at the end of 2024[12] - Total liabilities increased to CNY 1,059,286,652.92 from CNY 1,046,454,664.82[13] - Shareholders' equity rose to CNY 1,116,651,655.08 from CNY 1,072,318,529.90[14] Cash Flow - The company's cash flow from operating activities was CNY 9,502,983.24, a significant recovery from a negative cash flow of CNY -78,724,004.67 in the previous year[4] - Cash flow from operating activities for Q1 2025 was ¥9.50 million, a significant improvement from a negative cash flow of ¥78.72 million in Q1 2024[21] - The company experienced a net cash outflow from investing activities of ¥95.94 million in Q1 2025, compared to a net outflow of ¥53.19 million in Q1 2024[21] Expenses - Sales expenses increased by 35.74% due to growth in sales scale, while management expenses rose by 44.09% driven by personnel growth and increased advertising costs[7] - Total operating costs for Q1 2025 were ¥392.25 million, up 19% from ¥330.04 million in Q1 2024[16] - Research and development expenses for Q1 2025 were ¥14.20 million, an increase of 23% from ¥11.54 million in Q1 2024[16] Other Income and Financial Metrics - The company reported a 53.52% increase in other income, attributed to government subsidies and increased VAT deductions[7] - The company reported other income of ¥3.99 million in Q1 2025, compared to ¥2.60 million in Q1 2024[17] - The weighted average return on equity decreased slightly to 4.11%, down 0.11 percentage points from 4.22% at the end of the previous year[5] Shareholder Information - The company has a total of 21 common shareholders as of the reporting period[10] - The top 10 shareholders hold a combined 77,843,900 shares, representing 30.4% of total shares[10] Current Assets - Current assets decreased slightly to CNY 974,065,042.15 from CNY 978,691,399.88[12] - Cash and cash equivalents were CNY 126,369,229.19, down from CNY 153,844,100.35[12] - Accounts receivable totaled CNY 500,808,089.36, a decrease from CNY 515,761,697.86[12] - Inventory decreased to CNY 198,638,697.84 from CNY 219,431,699.52[12] Borrowings - Long-term borrowings increased by 45.15% as the company raised funds to meet its financial needs[7]

Financial Performance - The company's operating revenue for Q1 2025 was CNY 837,418,359.20, representing a 2.20% increase compared to CNY 819,353,705.09 in the same period last year[5] - The net profit attributable to shareholders was CNY 14,953,619.01, up by 2.32% from CNY 14,613,971.03 year-on-year[5] - The net profit after deducting non-recurring gains and losses decreased by 4.51% to CNY 13,202,740.82 from CNY 13,826,006.63 in the previous year[5] - Total revenue for Q1 2025 reached ¥837,418,359.20, an increase of 2.9% compared to ¥819,353,705.09 in Q1 2024[17] - Operating profit for Q1 2025 was ¥14,144,981.67, compared to ¥13,206,640.57 in Q1 2024, indicating a growth of 7.1%[18] - Net profit for Q1 2025 was ¥15,792,611.89, slightly up from ¥15,632,125.95 in Q1 2024, representing an increase of 1.0%[19] Assets and Liabilities - The company's total assets increased by 1.90% to CNY 5,970,218,684.42 from CNY 5,858,786,852.71 at the end of the previous year[5] - The total assets as of the end of the reporting period amounted to ¥5,970,218,684.42, compared to ¥5,858,786,852.71 at the end of the previous period, showing an increase of 1.9%[14] - Total liabilities increased to ¥4,001,341,681.05 from ¥3,905,638,281.14, marking a rise of 2.5%[14] - The total equity attributable to shareholders of the parent company was ¥1,902,726,531.16, up from ¥1,887,822,613.09, reflecting an increase of 0.7%[14] Cash Flow - The net cash flow from operating activities was negative at CNY -88,512,818.58, slightly worse than CNY -87,117,405.25 in the same period last year[5] - Operating cash inflow totaled $908.49 million, an increase from $880.82 million year-over-year[22] - Operating cash outflow amounted to $997.00 million, compared to $967.94 million in the previous year[22] - Net cash flow from operating activities was -$88.51 million, slightly worse than -$87.12 million year-over-year[22] - Cash inflow from investment activities was $5.00 million, down from $40.00 million in the previous year[22] - Cash outflow from investment activities reached $10.13 million, a decrease from $56.08 million year-over-year[22] - Net cash flow from investment activities was -$5.13 million, compared to -$16.08 million in the previous year[22] - Cash inflow from financing activities totaled $1.28 billion, up from $920.95 million year-over-year[23] - Cash outflow from financing activities was $1.13 billion, compared to $832.69 million in the previous year[23] - Net cash flow from financing activities increased to $149.87 million, from $88.25 million year-over-year[23] - The ending cash and cash equivalents balance was $180.53 million, down from $400.93 million in the previous year[23] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,783[8] - The largest shareholder, Hebei Jinxigroup Co., Ltd., holds 27.75% of the shares, totaling 94,111,100 shares[8] Research and Development - Research and development expenses for Q1 2025 were ¥31,147,284.20, slightly down from ¥31,180,471.13 in Q1 2024, indicating a decrease of 0.1%[18] - The company has not disclosed any significant new product developments or market expansion strategies in this report[11] Earnings Per Share - Basic and diluted earnings per share for Q1 2025 were both ¥0.0441, compared to ¥0.0431 in Q1 2024, representing an increase of 2.3%[19]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 金华春光橡塑科技股份有限公司2025 年第一季度报告 证券代码：603657 证券简称：春光科技 金华春光橡塑科技股份有限公司 2025 年第一季度报告 一、主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比上年同 | | | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期 期增减变动幅度 | | | | | (%) | | | 营业收入 | 566,320,675.07 | 364,023,793.31 | 55.57 | | 归属于上市公司股东的净利 | 2,911,528.71 | -4,0 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥498,043,499.95, representing a 59.31% increase compared to ¥312,616,886.25 in the same period last year[3] - Net profit attributable to shareholders decreased by 7.30% to ¥31,488,818.85 from ¥33,968,295.78 year-on-year[3] - The basic earnings per share fell by 30.77% to ¥0.27 from ¥0.39 in the previous year[5] - Total operating revenue for Q1 2025 reached ¥498,043,499.95, a significant increase of 59.3% compared to ¥312,616,886.25 in Q1 2024[19] - Net profit for Q1 2025 was ¥31,491,860.56, a decrease of 7.1% from ¥33,871,625.10 in Q1 2024[20] - Basic earnings per share for Q1 2025 were ¥0.27, down from ¥0.39 in Q1 2024, reflecting a decrease of 30.8%[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,146,123,391.63, down 1.75% from ¥2,184,438,873.65 at the end of the previous year[5] - The company's total assets amounted to ¥2,146,123,391.63, a slight decrease from ¥2,184,438,873.65 in the previous period[16] - Total liabilities decreased to ¥812,844,265.45 from ¥827,550,545.97, indicating a reduction of approximately 1.8%[16] - The equity attributable to shareholders was ¥1,328,317,550.77, down from ¥1,351,929,793.98, representing a decline of 1.7%[16] Cash Flow - The net cash flow from operating activities was negative at -¥237,442,093.34, compared to -¥127,541,827.37 in the same period last year[3] - Cash flow from operating activities was ¥239,340,223.43 in Q1 2025, slightly down from ¥240,701,364.15 in Q1 2024[22] - The net cash flow from operating activities was -237,442,093.34, compared to -127,541,827.37 in the previous period, indicating a decline in operational cash flow[23] - Total cash inflow from investment activities amounted to 663,727,864.42, significantly higher than 541.68 in the previous period[23] - The net cash flow from investment activities was 352,772,838.47, recovering from a negative cash flow of -9,136,977.06 in the previous period[23] - Cash inflow from financing activities totaled 16,984,450.00, a decrease from 90,768,273.47 in the previous period[25] - The net cash flow from financing activities was -54,466,525.00, compared to a positive cash flow of 90,113,224.49 previously, indicating a shift in financing strategy[25] - The ending balance of cash and cash equivalents increased to 654,455,584.73 from 468,629,313.36, reflecting a net increase of 60,933,543.52[25] - The company paid 61,450,975.00 in dividends and interest, indicating ongoing commitments to shareholders[25] Operational Metrics - The weighted average return on equity decreased by 2.07 percentage points to 2.40% from 4.47%[5] - The company experienced an increase in inventory and accounts receivable due to the rise in revenue[7] - Accounts receivable increased to ¥538.39 million from ¥325.72 million, indicating a significant rise in outstanding payments[14] - Total current assets decreased slightly to ¥1.81 billion from ¥1.85 billion[14] - Non-current assets include fixed assets valued at ¥93.12 million, up from ¥91.65 million[14] - The company has ongoing investments in construction projects amounting to ¥58.67 million, an increase from ¥56.09 million[14] - The company has a total of ¥30.94 million in investment properties, showing a slight decrease from ¥31.54 million[14] - The company reported a total cash outflow from operating activities of 496,773,423.63, compared to 376,335,950.37 in the previous period, indicating rising operational expenses[23] Shareholder Information - Total number of common stock shareholders at the end of the reporting period is 12,561[10] - The top 10 shareholders hold a combined 76.45% of the shares, with Zhejiang Jianfeng holding 26.29% and Zhuo Da holding 25.25%[10] - The top three shareholders, including Huang Hongyue, hold a combined 61.85% of the shares, indicating concentrated ownership[10] - The company has no significant changes in the number of shares lent or returned through margin trading[11] Research and Development - Research and development expenses increased to ¥18,419,656.12 in Q1 2025, compared to ¥13,314,767.30 in Q1 2024, reflecting a growth of 38.5%[20] Other Information - The company reported non-recurring gains and losses totaling ¥1,467,241.77 for the period[7] - The company did not disclose any new product developments, market expansions, or mergers and acquisitions during this reporting period[9]

Financial Performance - The company's operating revenue for Q1 2025 was CNY 618,910,665.47, representing a year-on-year increase of 25.16% compared to CNY 494,498,107.04 in the same period last year[4] - Net profit attributable to shareholders was CNY 218,567,101.74, up 48.13% from CNY 147,549,004.33 year-on-year[4] - Basic earnings per share rose to CNY 0.50, a 47.06% increase from CNY 0.34 in the same period last year[4] - The net profit excluding non-recurring gains and losses was CNY 208,976,403.83, marking a 53.30% increase from CNY 136,315,268.67 year-on-year[4] - The total profit for the period was CNY 259,915,720.06, compared to CNY 175,736,320.18 in the previous year, marking an increase of about 48%[20] - Operating profit for the period was CNY 259,904,968.64, up from CNY 176,366,401.91, reflecting a growth of approximately 47%[20] Cash Flow - The net cash flow from operating activities increased by 93.01%, reaching CNY 181,260,939.22, compared to CNY 93,913,720.58 in the previous year[4] - Cash flow from operating activities generated a net amount of CNY 181,260,939.22, compared to CNY 93,913,720.58 in the same quarter last year, indicating a year-over-year increase of 93%[24] - The company reported cash inflow from investment activities of CNY 1,291,300,379.67, a substantial increase from CNY 143,896,761.18 in Q1 2024[26] - Cash outflow from investment activities totaled CNY 1,006,366,733.99, compared to CNY 262,873,722.59 in the same quarter last year[26] - The company’s cash flow from financing activities generated a net amount of CNY 81,271,054.80, slightly down from CNY 90,747,637.45 in Q1 2024[26] Assets and Liabilities - Total assets at the end of the reporting period were CNY 5,814,847,133.34, reflecting a 3.78% increase from CNY 5,603,291,129.63 at the end of the previous year[5] - Total liabilities decreased to CNY 977,910,048.69 as of March 31, 2025, from CNY 987,405,152.49 at the end of 2024, a reduction of 0.5%[17] - Total current assets increased to ¥3,443,854,577.84 in the latest reporting period, compared to ¥3,331,373,369.70 previously, reflecting a growth of 3.4%[30] - The total liabilities decreased to ¥569,026,318.24 from ¥704,835,472.43, a reduction of approximately 19.2%[32] Shareholder Information - The top ten shareholders include Xu Jiangnan, holding 46.51% of shares, and Xu Jing, holding 13.50%[11] - The total equity attributable to shareholders increased to CNY 4,836,937,084.65 as of March 31, 2025, compared to CNY 4,615,885,977.14 at the end of 2024, marking a growth of 4.8%[18] Research and Development - Research and development expenses for Q1 2025 were CNY 20,722,319.47, a decrease of 9.1% from CNY 22,774,738.56 in Q1 2024[19] - Research and development expenses for Q1 2025 were ¥11,304,137.20, up from ¥9,686,583.82 in Q1 2024, indicating a focus on innovation[35] Non-Recurring Gains and Losses - The company reported a total of CNY 9,590,697.91 in non-recurring gains and losses for the period[6] - The company experienced a decrease in credit impairment losses, which improved from CNY -2,357,578.37 in Q1 2024 to CNY -780,792.60 in Q1 2025[20] Cash Position - Cash and cash equivalents as of March 31, 2025, totaled CNY 1,624,850,171.78, an increase of 50.8% from CNY 1,078,329,053.57 on December 31, 2024[14] - The ending balance of cash and cash equivalents reached ¥1,593,614,601.43, up from ¥2,309,350,155.08 at the end of the previous period[39]

天域生物科技股份有限公司2025 年第一季度报告 证券代码：603717 证券简称：天域生物 天域生物科技股份有限公司 2025 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 单位：元 币种：人民币 | 项目 | 本报告期 | 上年同期 | 本报告期比上年同 | | | --- | --- | --- | --- | --- | | | | | 期增减变动幅度(%) | | | 营业收入 | 225,272,371.07 | 211,157,093.90 | | 6.68 | | 归属于上市公司股东的净利润 | 13,768,228.59 | 9,028,099.06 | | 52.50 | | 归属于上市公司股东的扣除非经 常性损益的净利润 ...